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used the same dose of vitamin C did not
show any acute effect on the baseline (un-
stimulated) diameter, at the same time
showing an improvement in endothelial va-
somotor function. Our own observations
are also consistent with this. By showing
an increase in the lumen surface area, de-
rived from diameter changes, Drossos and
colleagues1 implied that vitamin C pro-
duces endothelium-independent dilatation.
Second, Drossos and colleagues1 pre-
sented their data as lumen surface area.
Why was this chosen? Also, was it derived
from r2? This also was not made clear in
the article.
Third, the results were actually pre-
sented as percentage change of lumen sur-
face area. With this approach, any small
change in measured diameter would be
magnified by conversion to lumen surface
area and further magnified by analysis of
percentage change. Was the change in di-
ameter statistically significant?
Finally, despite the larger increase in
lumen surface area seen with vitamin C
than with diltiazem, there did not appear to
be any effect on blood pressure. Did Dros-
sos and colleagues1 see a change in heart
rate and blood pressure in the vitamin C
group? If not, why not?
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Reply to the Editor:
We thank Madhavan for his interest in our
work. We have addressed these issues as
follows, in reverse order:
We did not measure blood pressure and
heart rate in the vitamin C group because
we were unaware that this would be nec-
essary.1,2 We did measure just the blood
pressure before and 2 hours after the oral
administration of 2 g vitamin C in 6 vol-
unteers (2 smokers and 4 nonsmokers). We
found no change in arterial blood pressure
after the administration of 2 g vitamin C,
but the heart rate was reduced by 5% to
10% in 4 subjects (2 smokers and 2 non-
smokers). We recommend repetition of this
trial by others.
The changes in diameter of the radial
artery were statistically significant in all
four groups (Table 1). The mean percent-
age increases in radial diameter were
7.38% in the control group and 18.75% in
the smoking group (P  .004 when ana-
lyzed by t test or P  .004 when analyzed
by Mann-Whitney U test). Also, the mean
percentage increases in radial diameter was
15.88% in patients with coronary artery
disease who received vitamin C and 7.76%
in patients with coronary artery disease
who received diltiazem (P  .037 when
analyzed by t test or P  .016 when ana-
lyzed by Mann-Whitney U test).
Lumen surface area measurement was
chosen because the Acuson equipment that
we used exhibits it (Figure 1 in the original
article). With respect to not using the r2
formula, we assumed that all readers are
aware of the meaning of our statement:
“All lumen surface areas (derived from the
estimated lumen diameter) are expressed in
square millimeters” in the Methods section
of our article.
Diameter measurements from the orig-
inal data are given in Table 1 as desired by
Madhavan. As to the new findings in Greek
patients from a remote mountain region of
Epirus, on a typical Mediterranean diet,
without discontinuation of multiple medi-
cations before the administration of vita-
min C, and notably heavy smokers, it ap-
pears that vitamin C plus “something” does
indeed cause endothelium-independent va-
sodilation in the radial artery of our pa-
tients. In addition, the objective of our
work is to protect a vessel that is exces-
sively handled during harvesting for coro-
nary artery bypass grafting.3 Therefore our
study with ultrasonographic probing,
which may be excessive (as many as 5
minutes of manipulation of the radial ar-
tery) does not necessarily imply a systemic
effect. Perhaps the study may be furthered
by studying other populations and arter-
ies.4,5
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TABLE 1. Diameter (expressed in mm) of radial arteries (mean SD) at baseline
and 2 hours after the oral administration of 2 g vitamin C in four groups of 15
subjects each
Baseline
2 hr after
vitamin C
P value
(Wilcoxon
test)
Control subjects 3.60 0.50 3.85 0.50 .008
Smokers 3.36 0.33 3.96 0.30 .001
Coronary artery disease, vitamin C 3.57 0.49 4.14 0.65 .001
Coronary artery disease, diltiazem 3.58 0.46 3.83 0.38 .009
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